Campbell introduces Encuity venture

Share this article:

Biopharma consultancy Campbell Alliance launched a market research and analytics group, one that could pose a threat to traditional MR firms.

The subsidiary, called Encuity Research, will be led by Campbell veteran Michael Turner.

It combines three components: SDI Health promotional and medical audit businesses that the consulting firm's parent, inVentiv Health, bought from IMS Health; service lines that came to Campbell after it was bought by inVentiv in 2011—RapidRecall (message effectiveness), Metropolitan Area Promotional Audit (syndicated audits of promotional activity), VisionCare (contact-lens market data), as well as a custom KOL mapping service; and Campbell's custom MR capability to support consulting projects.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.

Email Newsletters